Sarah C Hudson

Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist

Albert Zlotnik, A. Zlotnik, P. Gottlieb, 2005, Journal of Pharmacology and Experimental Therapeutics.

Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.

Beth A. Fleck, M. Kiankarimi, J. Wen, 2008, Bioorganic & medicinal chemistry letters.

Strategies for the modulation of phase II metabolism in a series of PKCε inhibitors.

R. Heim, J. Abt, A. Termin, 2014, Bioorganic & medicinal chemistry letters.

Optimization of Tubulysin Antibody–Drug Conjugates: A Case Study in Addressing ADC Metabolism

S. C. K. Sukuru, F. Loganzo, C. J. O’Donnell, 2016, ACS medicinal chemistry letters.

A high-throughput chemotaxis assay for pharmacological characterization of chemokine receptors: Utilization of U937 monocytic cells.

R. Struthers, F. Lio, Sarah C Hudson, 2005, Journal of pharmacological and toxicological methods.

Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.

Beth A. Fleck, M. Kiankarimi, Sarah C Hudson, 2008, Bioorganic & medicinal chemistry letters.

Substituted chromones and quinolones as potent melanin-concentrating hormone receptor 1 antagonists.

B. Dyck, Junko Tamiya, C. Heise, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2.

Troy D. Vickers, C. Heise, M. Kiankarimi, 2006, Bioorganic & medicinal chemistry letters.

Design, Synthesis, and Cytotoxic Evaluation of Novel Tubulysin Analogues as ADC Payloads.

J. Pandit, S. C. K. Sukuru, K. Parris, 2016, ACS medicinal chemistry letters.